Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures
Open Access
- 10 April 2024
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 30 (4) , 362-379
Abstract
The human immunodeficiency virus (HIV) epidemic is an ongoing global health problem affecting 38 million people worldwide with nearly 1.6 million new infections every year. Despite the advent of combined antiretroviral therapy (cART), a large percentage of people with HIV (PWH) still develop neurological deficits, grouped into the term of HIV-associated neurocognitive disorders (HAND). Investigating the neuropathology of HIV is important for understanding mechanisms associated with cognitive impairment seen in PWH. The major obstacle for studying neuroHIV is the lack of suitable in vitro human culture models that could shed light into the HIV-CNS interactions. Recent advances in induced pluripotent stem cell (iPSC) culture and 3D brain organoid systems have allowed the generation of 2D and 3D culture methods that possess a potential to serve as a model of neurotropic viral diseases, including HIV. In this study, we first generated and characterized several hiPSC lines from healthy human donor skin fibroblast cells. hiPSCs were then used for the generation of microglia-containing human cerebral organoids (hCOs). Once fully characterized, hCOs were infected with HIV-1 in the presence and absence of cART regimens and viral infection was studied by cellular, molecular/biochemical, and virological assays. Our results revealed that hCOs were productively infected with HIV-1 as evident by viral p24-ELISA in culture media, RT-qPCR and RNAscope analysis of viral RNA, as well as ddPCR analysis of proviral HIV-1 in genomic DNA samples. More interestingly, replication and gene expression of HIV-1 were also greatly suppressed by cART in hCOs as early as 7 days post-infections. Our results suggest that hCOs derived from hiPSCs support HIV-1 replication and gene expression and may serve as a unique platform to better understand neuropathology of HIV infection in the brain.Keywords
Funding Information
- NIH/NIDA (R01 DA052284)
- NIH/NIMH (R01 MH110360)
This publication has 98 references indexed in Scilit:
- Three-Dimensional Human Brain Organoids to Model HIV-1 Neuropathogenesis2022
- Modulation of OPRM1 Alternative Splicing by Morphine and HIV–1 NefJournal of Neuroimmune Pharmacology, 2021
- Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous systemJournal of NeuroVirology, 2016
- Development and characterization of a human microglia cell model of HIV-1 infectionJournal of NeuroVirology, 2016
- Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration ReconsideredCurrent HIV/AIDS Reports, 2015
- Neuropathogenesis of HIV: From Initial Neuroinvasion to HIV-Associated Neurocognitive Disorder (HAND)Current HIV/AIDS Reports, 2015
- HIV-1 target cells in the CNSJournal of NeuroVirology, 2014
- Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)Journal of NeuroVirology, 2014
- Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV‐1 infectionAnnals of Neurology, 1991
- The AIDS dementia complex: II. NeuropathologyAnnals of Neurology, 1986